SAN DIEGO (AP) -- Medical technology company CareFusion Corp. said Monday it will buy Medegen for $225 million in cash.
Medegen makes needleless access valves and other products that deliver intravenous medication to patients. CareFusion said the deal adds to its catheter-related infection prevention portfolio.
The acquisition is expected to be neutral to adjusted earnings in the first year and add to profits thereafter. The deal is expected to close by June 30.
CareFusion became a public company on Sept. 1 following its spinoff from Cardinal Health.
